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The high psychotropic activity of pyrimidine 
derivatives attracts attention and leads to the cre-
ation of new pyrimidine drugs which affect the cen-
tral nervous system. As psychotropic agents, a special 
attention deserve azolopyrimidine derivatives, in-
cluding pyrazolopyrimidines. Thus, the compounds 
with antiepileptic, anticonvulsant, sedative, anxio-
lytic activity (1,2), ligands of benzodiazepine site of 
GABA receptors (3) were found among the pyrazo-
lopyrimidine derivatives. 
This research aimed at synthesizing the N-
substituted derivatives of 1-(4-methoxyphenyl)-1,5-
dihydro-4Н-pyrazolo[3,4-d]pyrimidin-4-one.
The choice of substituent in the first position 
of pyrazolopyrimidine system was conditioned by 
the proved influence of the 4-metoxyphenyl radical 
in affecting the anticonvulsant activity of substanc-
es (4,5,6). 
To establish the prospects of synthesis and an 
optimization of further pharmacological screening, 
we performed a prediction of the biological activi-
ty that was planned for the synthesis of compounds 
using a PASS computer program. N-Substituted de-
rivatives of 1-(4-methoxyphenyl)-1,5-dihydro-4Н-
pyrazolo[3,4-d]pyrimidine-4-one were selected for a 
synthesis. Marked psychotropic activities such as an-
tiepileptic, anxiolytic, antidepressant, antineurotic, 
and convulsant activities (Ra≥0.50) were predicted 
for these compounds.
The initial compound – 
1-(4-methoxyphenyl)-1,5-dihydro-4H-pyrazolo[3,4-
d]pyrimidine-4-one 4 was obtained within two stag-
es. The first stage included the synthesis of inter-
mediate – ethyl 5-amino-1-(4-methoxyphenyl)-1H-
pyrazole-4-carboxylate 3 by an interaction with the 
ABSTRACT
The high psychotropic activity of pyrimidine derivatives attracts attention and leads to the creation of new 
pyrimidine drugs which affect the central nervous system. As psychotropic agents, special attention deserve 
azolopyrimidine derivatives, including pyrazolopyrimidines.
Thus, among the pyrazolopyrimidine derivatives, compounds with antiepileptic, anticonvulsant, sedative, 
anxiolytic activity, ligands of benzodiazepine site of GABA receptors have been found. In addition, the li-
gands of 5HT-6 receptors were identified that are promising for the treatment of central nervous system, 
muscle relaxants.
The purpose of this research was a synthesis of alkylated derivatives of 1-(4-methoxyphenyl)-1,5-di-
hydro-4H-pyrazolo[3,4-d]pyrimidine-4-ones.
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4-methoxyphenylhydrazine hydrochloride 1 and 
ethyletoxymethylencyanocetate 2 in isopropyl alco-
hol medium in the presence of triethylamine. Dur-
ing the second stage of the research, the resulting 
carboxylate 3 was heated in an excess of formamide 
for two days. As a result of this reaction, a target 
1-(4-methoxyphenyl)-1,5-dihydro-4H-pyrazolo[3,4-
d]pyrimidine-4-one 4 was obtained (Fig. 1).  
Synthesis of N-substituted deriva-
tives of 1-(4-methoxyphenyl)-1,5-dihydro-4Н-
pyrazolo[3,4-d]pyrimidin-4-one was carried out by 
an interaction of pyrazolo[3,4-d]pyrimidine-4-one 4 
with N-arylsubstituted α-chloroacetamides, 2-chlo-
ro-1-(4-arylpiperazine-1-yl)-ethanones and 2-chlo-
ro-N-(4-chlorobenzyl)acetamide (Fig. 2). The reac-
tion was performed maintaining the mixture of re-
agents for two hours at 70°C in dimethylformamide 
medium in the presence of NaHCO3.
The presence of several reaction centers in the 
molecule of pyrazolopyrimidine 4 made it possible 
to achieve several directions of the reaction: substi-
tution can occur at the nitrogen atom in position 5 
(route a) as well as at the oxygen atom in position 4 
(route b) (Fig. 2).  
Such reactivity of pyrazolopyrimidine was pre-
determined by its tendency to tautomeric transfor-
mations. We also took into account the difficulty of 
regioselectively introducing the aforementioned rad-
icals in the structure of 1-(4-methoxyphenyl)-1,5-di-
hydro-4H-pyrazolo[3,4-d]pyrimidin-4-one 4 and 
determining the position of substituents due to the 
Figure 1. Synthesis of 1-(4-methoxyphenyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidine-4-one 4 
Compound Yield, % M.p., °C Calculated N, % Found N, % Mol. formula [MH+]
4 89 180-182 23.13 23.22 C12H10N4O2 −
5.1 85 265-287 18.66 18.78 C20H17N5O3 376
5.2 88 280-282 17.27 17.43 C21H19N5O4 −
5.3 84 243-245 16.08 16.23 C22H21N5O5 −
5.4 85 270-272 17.09 17.24 C20H16ClN5O3 410
5.5 88 268-270 17.27 17.39 C21H19N5O4 −
5.6 86 285-287 17.98 18.02 C21H19N5O3 390
5.7 84 205-207 17.98 18.04 C21H19N5O3 −
5.8 81 250-252 16.52 16.66 C21H18ClN5O3 −
5.9 82 265-257 16.16 16.31 C22H19N5O5 −
5.10 80 255-257 16.70 16.79 C21H17N5O5 −
5.11 84 230-232 18.91 19.02 C24H24N6O3 444
5.12 84 245-247 17.71 17.98 C25H26N6O4 −
Table 1. Data of 1-(4-methoxyphenyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidine-4-one derivatives obtained 4, 5.1-12 
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probability of formation of a mixture of N- and O-
substituted products. 
Due to chromato-mass spectrometry data the 
synthesized products were individual substances 
(Table 1) which were obtained with the satisfacto-
ry yields. After the crystallization from isopropyl al-
cohol, the synthesized compounds became white or 
light yellow crystalline substances with well-defined 
melting points. 
Comparing the 1H NMR spectra of the syn-
thesized compounds 5 with the spectra of initial 
1-(4-methoxyphenyl)-1,5-dihydro-4H-pyrazolo[3,4-
d]pyrimidine-4-one 4, the absence of imine signal 
proton of pyrimidine cycle was noted but this pro-
ton disappeared in both of the proposed structures. 
Furthermore, a singlet of NH-group of amide resi-
due at δ 12.46 ppm (5.1-5.8) and additional aryl pro-
tons caused the multiplicity and intensity which cor-
responded to the nature and location of the substit-
uents. The spectra of compounds 5.10-12 were char-
acterized by two multiplets at 3.10-3.73 ppm corre-
sponding to protons of piperazine cycle. The spec-
trum of compounds 5.8 was characterized by a dou-
blet at 4.30 ppm corresponding to protons of the 
methylene group in a benzyl radical. 
The position of the proton signals of methy-
lene groups in the alkyl radical at 4.62-4.92 ppm 
showed the reaction in the direction A (Fig. 2). Since 
the formation of the type 6 compounds, the signals 
shifted to 0.2-0.4 ppm. For a more reliable verifica-
tion of N-substituted derivatives formation, we used 
the NOESY spectroscopy data following the exam-
ple of a compound 5.1. NOESY spectrum which was 
characterized by cross-peak CH2 of the protons of 
acetamide residue and CH proton at position 6 of 
pyrazolo[3,4-d]pyrimidine system. This clearly in-
dicated the formation of an N-substituted derivative 
and, therefore, confirmed the formation of  the com-
pounds of type 5.
Figure 2. Synthesis of N-substituted derivatives of 1-(4-methoxyphenyl)-1,5-dihydro- -pyrazolo[3,4-d]pyrimidin-4-one 5
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Experimental Part 
All of the solvents and reagents were obtained 
from commercial sources. The melting points (°C) 
were measured with a Kofler melting point appara-
tus and were not corrected. 1H NMR spectra were 
recorded on a Varian Mercury (200 MHz) spectrom-
eter in DMSO-d6 using TMS as an internal standard 
(chemical shifts are in ppm). NOESY spectra were re-
corded on a Varian Gemini (300 MHz) spectrome-
ter in DMSO-d6 using TMS as an internal standard 
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5.5 9.80 8.45 8.30
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7.28-7.00, 4Н, m 
6.96-6.80, 1Н, m
4.94 3.823.70 -




4.89 3.80 2.22, 3Н, s, СН3
5.7 - 8.41 8.31 7.62-7.32, 5Н, m7.09, 2Н, m 4.62 3.75 2.42, 3Н, s, СН3





4.75 3.75 4.30, 2Н, d CH2Bn




4.81 3.75 4.22, 4H, s, 2CH2




4.85 3.75 5.95, 2Н, s, СН2
Table 2. 1H NMR spectra of the synthesized compounds 4, 5.1-12
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with РЕ SCIEX API 150EX chromatograph equipped 
with a mass spectrometer.
1-(4 -methoxyphenyl)-1,5-dihydro-4H-
pyrazolo[3,4-d]pyrimidine-4-one 4
The mixture of 0.1 mol (17.46g) of  4-methoxy-
phenylhydrazine hydrochloride 1 and 0.1 mol (15.73 
ml) of ethylethoxymetylencyanocetate 2 was heat-
ed in isopropyl alcohol with triethylamine (1.1 mol, 
15.28 ml) at 60°C for four hours. The reaction mix-
ture was cooled at room temperature; the isopro-
pyl alcohol was evaporated under the vacuum, 
and the residue was diluted with 200 ml of water. 
Then the formed precipitate of ethyl 5-amino-1-(4-
methoxyphenyl)-1H-pyrazole-4-carboxylate 3 was 
filtered, rinsed with water, and dried. 0.1 mol of the 
obtained carboxylate 3 was heated in 200 ml of for-
mamide at 120˚С for 48 hours.  The reaction mixture 
was cooled at room temperature, the precipitate was 
isolated, diluted with isopropyl alcohol, filtered, and 
dried at 60-70˚C for 12 hours. 
General procedure of the synthesis of N-sub-
stituted derivatives of 1-(4-methoxyphenyl)-1,5-
dihydro-4Н-pyrazolo[3,4-d]pyrimidin-4-one 5.
0.0015 mol (0.12 g) of sodium bicarbonate and 
0.001 mol of appropriate alkyl halide were added to a 
solution of 0.001 mol (0.24 g) of 1-(4-methoxyphenyl)-
1,5-dihydro-4H-pyrazolo[-3,4-d] pyrimidine-4-one 
4 in 10 ml of dimethylformamide . Then this was 
heated for 5 hours at 70˚C. The reaction mixture was 
cooled at room temperature, the precipitate was iso-
lated, diluted by isopropyl alcohol, filtered, and dried. 
It became crystallized from isopropanol.
CONCLUSIONS 
Using the PASS program, a synthe-
sis of potential anticonvulsants of derivatives of 
pyrazolo[3,4-d]pyrimidine was planned. The syn-
thesis of 1-(4-metoxyphenyl)-1,5-dihydro-4H-
pyrazolo[3,4-d]pyrimidine-4-one and their alkyla-
tion was carried out. It was found that the reaction of 
1-(4-metoxyphenyl)-1,5-dihydro-4H-pyrazolo[3,4-
d] pyrimidine-4-one with α-chloroacetamides, 
2-chloro-1-(4-arylpiperazine-1-yl)-ethanones and 
2-chloro-N-(4-chlorobenzyl)acetamide in DMFA 
conditions - NaHCO3 was selectively performed at 
position 5 of the pyrazolopyrimidine cycle to form 
N-substituted derivatives.
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